Brian Piekos
Chief Financial Officer · KalVista Pharmaceuticals, Inc.
- 2025
- Jun 11, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Piekos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Venrock Healthcare Capital Partners III, L.P. - $3.69M in KALV purchases and sales in the last 12 months
- Christopher Yea - $1.23M in KALV purchases and sales in the last 12 months
- Benjamin L. Palleiko - $1.19M in KALV purchases and sales in the last 12 months
- Paul K. Audhya - $430K in KALV purchases and sales in the last 12 months
- Nicole Sweeny - $241K in KALV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian Piekos?
Brian Piekos is a corporate insider, tracked as Chief Financial Officer of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Brian Piekos last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 6 filings going back to 2025.
Has Brian Piekos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($165K) across all tracked filings.
